Regeneron Pharmaceuticals Stock News & Updates

[WKN: 881535 | Symbol: REGN]

Regeneron: Billion-Dollar Deal with Sanofi and New Approvals Secure Market Position

Revenue climbed in the third quarter to $5.1 billion, driven by sales figures for Dupixent and Eylea...

Regeneron - Pharma Company Impresses with a Strong Outlook Thanks to Dupixient and Eylea!

Business drivers: Regeneron Pharmaceuticals (REGN ) specializes in the development of new drugs and therapies...

Stocks in Action USA: Regeneron Pharmaceuticals, Ulta Beauty, Zscaler

Regeneron (REGN) stock plummets – drug candidate against COPD disappointed in a late phase! The...

  • ‹
  • 1
  • ›